Drug Profile
Research programme: nitric oxide synthase type II inhibitors - AstraZeneca
Alternative Names: ARC-102222; ARC-85016; Inducible nitric oxide synthase inhibitors - AstraZeneca; iNOS inhibitors - AstraZenecaLatest Information Update: 23 Jan 2007
Price :
$50
*
At a glance
- Originator AstraZeneca R&D Charnwood
- Class
- Mechanism of Action Nitric oxide synthase type II inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis